Tangram is excited to announce the appointment of Kimberly Sanders to its Board of Directors. A dynamic leader with extensive experience in the pharmaceutical industry, Sanders will bring her strategic vision and passion for public health to enhance Tangram’s mission of empowering individuals with disabilities.

As the Senior Vice President of US Vaccines at GSK, Sanders played a pivotal role in revitalizing the company’s vaccine business. Her leadership is characterized by innovative strategies and a commitment to community engagement, making her a perfect fit for Tangram as it strives to promote inclusion and accessibility for all. “We are thrilled to welcome Kim to Tangram’s Board of Directors,” said Sam Criss, President and CEO of Tangram. “Her background and dedication to empowering underserved communities will provide us with the ultimate insights needed to expand our impact and reach new heights.”

“At Tangram, we are constantly seeking innovative ways to enhance our programs, and Kim’s experience in leading strategic initiatives will be invaluable as we look to the future,” Criss states. “Her focus on community health aligns perfectly with our mission, and we are excited to collaborate with her to create opportunities that promote independence and empowerment.

Tangram is dedicated to promoting inclusion, independence, and empowerment for individuals with disabilities through a wide range of programs and services. For more information about Tangram and its mission, please visit: thetangramway.org

For more information about this press release, please email Madison Scott, Marketing and Business Development Manager at mscott@thetangramway.org.